Literature DB >> 17225517

[The effects of endoscopic sinus surgery on nasality and nasal patency].

Jianxin Yue1, Weijia Kong, Hui fang Tan, Xingao Xiong, Xiaomeng Zhang, Yanjun Wang, Song Zhang.   

Abstract

OBJECTIVE: The purpose of this study was to describe the changes of resonance characteristics of the nasal cavity (including nasal sinuses) and nasal airway resistance (NAR) after endoscopic sinus surgery (ESS), through objective measurement of nasality and NAR before and after ESS.
METHOD: Sixty- eight patients received the examinations of nasality and NAR using Nanometer and Atmos Rhinomanometry before and after ESS separately. RESULT: The nasality of patients with type III and type II stage 2, stage 3 chronic sinusitis was obviously improved ( P <0. 05), but still below the normal range 1 month after ESS. The nasality didn't recover to the normal level 3 months postoperatively. However the total NAR apparently decreased 1 months after ESS ( P <0. 01) and returned to normal 3 months postoperatively. Nasality and the total NAR of patients in type II stage 1 turned to normal 1 month after ESS. There are no distinctive changes in nasality and total NAR of type I stage 1 patients.
CONCLUSION: The total NAR significantly decreased close to normal among the patients with severe sinus or/and nasal lesions after ESS, however nasality continued aberrant for a relatively long period. It is suggested that nasality can't be ameliorated immediately after ESS. On the contrary, it is possible to bring some undesirable effects to the professional voice users, such as announces, for the changed resonance characteristics of the nasal cavity due to the excessive destruction of its normal structure.

Entities:  

Mesh:

Year:  2006        PMID: 17225517

Source DB:  PubMed          Journal:  Lin Chuang Er Bi Yan Hou Ke Za Zhi


  1 in total

1.  The use of automatic speech recognition showing the influence of nasality on speech intelligibility.

Authors:  S Mayr; K Burkhardt; M Schuster; K Rogler; A Maier; H Iro
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-04-27       Impact factor: 2.503

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.